The U.S. Food and Drug Administration and U.S. Marshals seized nearly 90,000 bottles of a dietary supplement from a South Beloit manufacturer for containing a potentially harmful ingredient.
The product contained kratom, a botanical substance that grows naturally in Thailand, Malaysia, Indonesia and Papua New Guinea. Serious concerns exist regarding the toxicity of kratom in multiple organ systems. Consumption of kratom can lead to a number of health impacts including respiratory depression, vomiting, nervousness, weight loss and constipation.
In February 2014, the FDA issued an alert that allows U.S. officials to detain imported dietary supplements and ingredients that are, or contain, kratom.
The product seized in South Beloit was manufactured for and held by Dordoniz Natural Products LLC, and marketed under the brand name RelaKzpro. The amount of product taken was worth more than $400,000.
“We have identified kratom as a botanical substance that could pose a risk to public health and have the potential for abuse,” said Melinda Plaisier, the FDA’s associate commissioner for regulatory affairs. “The FDA will continue to exercise our full authority under law to take action on these new dietary ingredients, especially if they ignore the notification requirements, as part of our commitment to protecting the health of the American people.”
Kratom has been indicated to have both narcotic and stimulant-like effects and withdrawal symptoms may include hostility, aggression, excessive tearing, aching of muscles and bones and jerky limb movements.